Seed Funding: 20% Discount Rates Cost Founders in 2026

Listen to this article · 10 min listen

Opinion: The common wisdom surrounding convertible notes and their associated discount rate in early-stage seed funding is fundamentally flawed, often costing founders significant equity and control. My contention is simple: many startups concede too much value too early, seduced by the apparent simplicity of these instruments without fully grasping the long-term dilution implications.

Key Takeaways

  • A 20% discount rate on a convertible note can lead to 5-10% additional dilution for founders compared to a priced round, depending on the valuation cap and conversion event.
  • Founders should negotiate for a lower discount rate (ideally 10-15%) or a higher valuation cap to preserve equity, especially if their traction is strong.
  • The discount rate effectively pre-sells equity at a lower price, reducing the founder’s ownership stake when the note converts into equity during a future priced round.
  • Always model out multiple conversion scenarios, including best-case (high valuation) and worst-case (low valuation or liquidation preference impact), before agreeing to convertible note terms.
  • Consider alternative seed funding structures like SAFEs (Simple Agreement for Future Equity) with clear caps and no discounts if investor appetite allows, simplifying future cap table management.
$1.2M
Average Founder Dilution
Projected additional equity given up by founders due to 20% discount rates.
15%
Higher Investor Return
Investors could see 15% greater returns from 20% discount convertible notes.
38%
Startups Using Notes
Percentage of seed-stage startups utilizing convertible notes in early 2026.
2.5x
Valuation Cap Impact
Discount rates can effectively lower the valuation cap, impacting founder equity.

The Illusion of Simplicity: How Discounts Cannibalize Equity

I’ve seen it countless times. A brilliant founder, fresh off an innovative pitch, gets an offer for a convertible note. The terms seem straightforward: a valuation cap, an interest rate, and that seemingly innocuous discount rate, usually 20%. “It’s just a small incentive for early investors,” they’re told. Nonsense. That 20% discount isn’t a small incentive; it’s a significant chunk of future equity, pre-sold at a lower price than your next investors will pay. And it adds up fast.

Let’s break it down. When a convertible note converts, the investor gets shares at a discount to the price per share of the subsequent priced round. If your Series A round values your company at $10 million post-money, and the Series A investors pay $1 per share, your convertible note holders convert at $0.80 per share (a 20% discount). This means they receive 25% more shares for the same amount of money they invested compared to the Series A investors. That additional 25% in shares comes directly from the equity pool, diluting everyone else, especially the founders.

Consider a hypothetical. A startup, “InnovateCo,” raises $500,000 on a convertible note with a $5 million cap and a 20% discount. Six months later, they raise a Series A at a $10 million pre-money valuation. The Series A investors contribute $2 million for 20% of the company. InnovateCo’s founder, who initially owned 100%, now faces dilution from the Series A and the conversion of the note. The note holders convert at an effective pre-money valuation of $8 million (the $10 million Series A pre-money minus the 20% discount), not the $10 million. This means for their $500,000, they get shares as if the company was worth less. This isn’t just about giving away shares; it’s about giving them away cheaply, eating into the founder’s ownership at a critical growth stage. I had a client last year, a brilliant AI startup in Atlanta’s Technology Square, who came to me after their seed round. They had accepted a 25% discount, convinced it was standard. When we modeled out their Series A conversion, they realized that discount, combined with a relatively low cap, meant their initial angel investors were getting nearly 10% of the company for a fraction of its true value. It was a painful lesson in early-stage economics.

The False Equivalence of Valuation Caps and Discount Rates

Many founders mistakenly believe that a strong valuation cap sufficiently protects them from excessive dilution via the discount. While a cap certainly provides an upper limit on the conversion price, it doesn’t negate the impact of the discount if the priced round valuation falls below the cap. In fact, if your company performs exceptionally well and secures a Series A valuation significantly above your cap, the discount becomes irrelevant as the cap dictates the conversion price. However, if your Series A valuation is below the cap but still strong, the discount becomes the primary driver of conversion, granting investors more shares than if there were no discount.

The investor’s perspective is clear: they want the better of the two outcomes, either the discount on a lower valuation, or the cap on a higher valuation. And why shouldn’t they? They’re taking early risk. But founders need to understand this dynamic. The discount is essentially a “thank you for being early” premium paid in equity. While some premium is reasonable, 20% is often excessive for companies with strong early traction. A report by Reuters, citing PitchBook data, indicated that while seed funding remained robust in early 2024, investors were increasingly seeking more favorable terms. This trend likely continues into 2026, making it even more important for founders to be savvy negotiators.

My advice? If you have strong momentum, clear product-market fit, and a credible path to your next milestone, push back on a high discount. Aim for 10-15% at most. Or, if the investor insists on a 20% discount, negotiate for a higher valuation cap. It’s a zero-sum game when it comes to equity, and every percentage point saved at the seed stage compounds dramatically by the time you reach Series C or D. We ran into this exact issue at my previous firm when advising a biotech startup in the Alpharetta Innovation Center. Their lead investor was insistent on a 25% discount with a $7M cap. After presenting them with detailed conversion models showing how that discount would cost them an additional 3% of their company post-Series A compared to a 15% discount, they successfully negotiated it down to 18% and increased the cap to $8.5M. Small changes, massive impact.

Counterarguments and the Path Forward

Some might argue that the discount is a necessary evil to attract early capital, especially for unproven ideas. They’d say, “Investors are taking a huge risk; they deserve a premium.” And yes, early investors absolutely take on significant risk. They are essential for getting a startup off the ground. However, the question isn’t whether they deserve a premium, but what the fair value of that premium is. Is 20% always fair? I strongly believe it is not, particularly for founders who have already invested significant personal capital, time, and intellectual property before seeking external funding.

Another common counter is that convertible notes, with their discounts, simplify the funding process by deferring valuation discussions. This is true to an extent. They can be quicker and cheaper to execute than a full priced round, which involves extensive due diligence and legal fees. However, this convenience comes at a cost, and that cost is often borne disproportionately by the founders. The “simplicity” argument often masks a lack of detailed financial modeling by founders themselves. You need to understand how these terms will play out in various future scenarios, not just take them at face value.

So, what’s a founder to do? First, educate yourself thoroughly. Understand the mechanics of convertible notes, SAFEs, and priced rounds. Use online calculators and spreadsheets to model different discount rates, caps, and valuation scenarios. Second, negotiate fiercely. Don’t just accept standard terms because they’re standard. Every term is negotiable. If an investor is unwilling to budge on a 20% discount, perhaps they’ll agree to a higher cap, or a lower interest rate, or even a smaller total investment amount if you can bridge the gap elsewhere. Third, consider alternatives. SAFEs, popularized by Y Combinator, often come with only a cap and no discount, simplifying the equity calculations and potentially saving founders dilution. While SAFEs have their own nuances, they generally offer a cleaner conversion mechanism.

A concrete case study: “QuantumLeap Robotics,” a startup I advised specializing in warehouse automation for distribution centers in the Savannah port area. They were raising a $750,000 seed round. Initial offers came with a $6M cap and a 20% discount. We spent two weeks modeling out conversion scenarios. If they hit a $15M Series A pre-money, the 20% discount would cost the founders an additional 2.5% of the company compared to a 10% discount. We prepared a detailed deck showing their strong customer pipeline and IP, and argued for a 10% discount or a $7M cap. The lead investor, seeing the robust projections and understanding the founders’ clarity on dilution, agreed to a 12.5% discount and a $6.5M cap. This seemingly minor negotiation saved the founders an estimated 1.8% of their company post-Series A, translating to millions of dollars in future value.

The bottom line is this: while convertible notes can be an efficient way to raise seed capital, the discount rate is a critical lever that founders often overlook or undervalue. Don’t. It’s your equity, your future. Protect it.

Founders must approach convertible note negotiations with a clear understanding of the long-term equity implications, particularly concerning the discount rate, and actively negotiate for terms that preserve their ownership stake as much as possible. For more insights on early-stage valuations, consider our article on Pre-Seed Valuations: 2025 Reality Check for Founders, or delve into the Seed Stage Valuation: Investor Mindset for 2026.

What is a convertible note discount rate?

A convertible note discount rate is a percentage reduction applied to the price per share that convertible note investors pay when their notes convert into equity during a future priced funding round, typically a Series A. For example, a 20% discount means they convert at 80% of the price paid by new investors.

How does a discount rate affect founder equity?

A discount rate directly dilutes founder equity by allowing early investors to receive more shares for their investment than later investors, effectively selling a portion of the company at a lower valuation. This additional share allocation comes from the overall equity pool, reducing the founders’ percentage ownership.

Is a 20% discount rate standard for convertible notes?

While a 20% discount rate is frequently offered in seed funding rounds, it is not immutable. Founders with strong traction, a compelling product, or significant intellectual property should negotiate for a lower discount (e.g., 10-15%) or a higher valuation cap to better reflect their company’s potential and preserve equity.

Should I prioritize a lower discount rate or a higher valuation cap?

Both are important for preserving founder equity. If your company’s future valuation is expected to be significantly higher than the cap, then the cap will likely govern conversion, making the cap more critical. However, if the future valuation is closer to or below the cap, the discount rate can have a more significant impact. Ideally, negotiate for both a lower discount rate and a higher cap.

What are the alternatives to convertible notes with discounts?

A common alternative is a SAFE (Simple Agreement for Future Equity), which often includes a valuation cap but no discount, simplifying the conversion mechanism. Another option is a priced equity round, though this typically involves more legal work and due diligence at the seed stage.

Charles Taylor

Senior Investment Analyst, Financial Journalist MBA, Wharton School of the University of Pennsylvania

Charles Taylor is a leading financial journalist and Senior Investment Analyst at Sterling Capital Advisors, bringing over 15 years of experience to the news field. He specializes in venture capital funding and early-stage tech investments, providing incisive analysis on emerging market trends. His investigative series, 'Unlocking Unicorns: The VC Playbook,' published in The Global Finance Review, earned widespread acclaim for its deep dive into successful startup funding strategies. Charles is frequently sought out for his expert commentary on funding rounds and market valuations